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Energy-adjusted magnesium intake was nonsignificantly inversely related to risk of colorectal cancer (n¼2328) in the Netherlands
Cohort Study on Diet and Cancer that started in 1986 (n¼58279 men and 62573 women). Statistically significant inverse trends in
risk were observed in overweight subjects for colon and proximal colon cancer across increasing quintiles of magnesium uptake
(P-trend, 0.05 and 0.02, respectively). Although an overall protective effect was not afforded, our results suggest an effect of
magnesium in overweight subjects, possibly through decreasing insulin resistance.
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Two recent prospective cohort studies among women showed an
inverse association between magnesium intake and colorectal
cancer (Larsson et al, 2005) and colon cancer only (Folsom and
Hong, 2006). Magnesium supplementation reduced colon cancer
risk in animal experiments (Mori et al, 1993). Magnesium plays a
role in genomic stability and DNA repair (Hartwig, 2001; Larsson
et al, 2005) and may reduce hyperinsulinaemia (Paolisso et al,
1992; Rodriguez-Moran and Guerrero-Romero, 2003), a risk factor
for colorectal cancer (Giovannucci, 1995; Schoen et al, 1999). In
the Netherlands Cohort Study (NLCS), we investigated colorectal
cancer in both sexes in relation to magnesium intake, particularly
in overweight subjects, given the suggested beneficial effects of
magnesium on insulin resistance (Fung et al, 2003).
MATERIALS AND METHODS
The NLCS started in 1986 and included 58279 men and 62573
women aged 55–69 years. At baseline, cohort members completed
a mailed, self-administered questionnaire on dietary habits,
anthropometry, and other risk factors for cancer (Van den Brandt
et al, 1990a). Habitual consumption of food and beverages during
the year preceding baseline was assessed using a 150-item
semiquantitative food frequency questionnaire (Goldbohm et al,
1994). From this, nutrient intakes were calculated from the 150
food items using the computerized Dutch food composition table
(Nevo-table, 1986). Nutrient intake was adjusted for energy intake
by the residual method (Willett and Stampfer, 1986).
Data were processed and analysed using the case–cohort
approach, enumerating the cases for the entire cohort, and
estimating the person-years at risk from a subcohort of 5000
subjects, which was randomly sampled from the entire cohort
immediately after the baseline measurement and followed up for
vital status. Follow-up for cancer incidence is established by record
linkage with the Netherlands Cancer Registry and PALGA, a
nationwide pathology database (Van den Brandt et al, 1990b).
After 13.3 years of follow-up, a total of 2679 incident colorectal
cancer cases were reported. Cases and subcohort members were
excluded if they reported cancer other than non-melanoma skin
cancer, or had incomplete data for diet, anthropometry, or
confounders. Finally, 4125 subcohort members and 2328 colorectal
cancer cases were available for analysis.
Statistical analysis
Incidence rate ratios (RR) and 95% confidence intervals for
colorectal cancer and subsites were estimated using Cox propor-
tional hazards models (Cox, 1972), with Stata software (Cleves
et al, 2002). Standard errors were estimated using the robust
Huber–White sandwich estimator to account for additional
variance introduced by sampling from the cohort (Schoenfeld,
1982). All RRs are adjusted for confounders that contributed
significantly to the model or influenced the RRs of magnesium
more than 10% (age, sex, family history of colorectal cancer, body
mass index (BMI), physical activity, energy-adjusted intakes of fat,
fiber, calcium, folate, beta-carotene, vitamins E and B6, alcohol,
and energy intake).
RESULTS
Mean (7s.d.) energy-adjusted magnesium intake was 332 (758)
and 292 (748)mgday
 1 among subcohort men and women,
respectively. Important sources of magnesium were wholewheat
bread, dairy, pulses, coffee, tea, and peanuts/peanut butter.
Magnesium supplements were used by only 0.2% of individuals.
Baseline characteristics of the subcohort are presented in
Supplementary Table. Magnesium intake was weakly inversely
associated with colorectal and colon cancer risks in men and
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years of follow-up yielded similar results. Because men and women
showed comparable results, we combined them in analyses
stratified by BMI. Table 2 shows that the association with
colorectal cancer and its subsites varied by BMI: for those with a
BMIX25kgm
 2, this was inverse (except rectum), with P-trend
reaching significance for colon, and especially proximal colon
cancer. The RRs of proximal colon cancer for increasing quintiles
of magnesium were 1.0, 0.69, 0.65, 0.48, and 0.54, respectively
(P-trend¼0.02). For those with BMI o25kgm
 2, there was no
Table 1 Relative rates (RRs) of colorectal cancer according to energy-adjusted magnesium intake, Netherlands Cohort Study 1986–1999
Quintiles of energy-adjusted magnesium intake (mgday
 1)
Q1 Q2 Q3 Q4 Q5 P-trend
Men
Quintile cutoffs (mgday
 1) o286 286–316 317–341 342–373 4373
Median (mgday
 1) 264 303 329 356 401
Person-years in subcohort 4761 4823 4919 4836 4757
Colorectal cancer
Cases 275 281 297 264 263
Age-adjusted RR
a 1.0 1.00 (0.80–1.25) 1.04 (0.83–1.29) 0.95 (0.76–1.18) 0.96 (0.77–1.20) 0.57
Multivariate RR
b 1.0 0.96 (0.75–1.22) 0.96 (0.74–1.26) 0.87 (0.64–1.17) 0.91 (0.62–1.35) 0.50
Colon cancer
Cases 192 180 185 167 159
Age-adjusted RR
a 1.0 0.92 (0.71–1.18) 0.92 (0.72–1.18) 0.86 (0.67–1.10) 0.83 (0.64–1.07) 0.13
Multivariate RR
b 1.0 0.89 (0.67–1.17) 0.87 (0.64–1.19) 0.82 (0.59–1.15) 0.85 (0.54–1.33) 0.41
Proximal colon cancer
Cases 77 81 86 73 64
Age-adjusted RR
a 1.0 1.03 (0.73–1.45) 1.07 (0.76–1.50) 0.94 (0.66–1.33) 0.83 (0.58–1.20) 0.27
Multivariate RR
b 1.0 0.95 (0.65–1.38) 0.95 (0.63–1.43) 0.81 (0.51–1.28) 0.73 (0.39–1.36) 0.28
Distal colon cancer
Cases 103 90 95 90 85
Age-adjusted RR
a 1.0 0.85 (0.62–1.17) 0.88 (0.65–1.21) 0.86 (0.63–1.18) 0.82 (0.60–1.14) 0.30
Multivariate RR
b 1.0 0.84 (0.59–1.19) 0.86 (0.58–1.27) 0.87 (0.57–1.31) 0.94 (0.53–1.64) 0.85
Rectum cancer
c
Cases 83 101 112 97 104
Age-adjusted RR
a 1.0 1.19 (0.86–1.65) 1.29 (0.94–1.78) 1.15 (0.83–1.59) 1.25 (0.91–1.73) 0.27
Multivariate RR
b 1.0 1.12 (0.79–1.59) 1.18 (0.80–1.73) 0.99 (0.63–1.55) 1.07 (0.61–1.89) 0.94
Women
Quintile cutoffs (mgday
 1) o256 256–279 280–300 301–326 4326
Median (mgday
-1) 236 269 289 313 349
Person-years in subcohort 4902 5152 5157 5014 5258
Colorectal cancer
Cases 217 185 172 186 188
Age-adjusted RR
a 1.0 0.84 (0.66–1.07) 0.79 (0.62–1.01) 0.88 (0.69–1.12) 0.88 (0.69–1.12) 0.42
Multivariate RR
b 1.0 0.83 (0.63–1.08) 0.78 (0.58–1.06) 0.89 (0.63–1.24) 0.89 (0.59–1.35) 0.77
Colon cancer
Cases 159 136 127 135 138
Age-adjusted RR
a 1.0 0.94 (0.64–1.10) 0.80 (0.61–1.05) 0.87 (0.66–1.14) 0.88 (0.67–1.15) 0.45
Multivariate RR
b 1.0 0.83 (0.62–1.12) 0.79 (0.57–1.11) 0.89 (0.61–1.29) 0.89 (0.56–1.40) 0.77
Proximal colon cancer
Cases 95 70 64 70 84
Age-adjusted RR
a 1.0 0.73 (0.52–1.03) 0.68 (0.48–0.97) 0.77 (0.54–1.08) 0.92 (0.66–1.28) 0.70
Multivariate RR
b 1.0 0.71 (0.49–1.03) 0.66 (0.44–1.01) 0.75 (0.47–1.20) 0.86 (0.49–1.52) 0.69
Distal colon cancer
Cases 58 61 60 59 50
Age-adjusted RR
a 1.0 1.02 (0.69–1.50) 1.01 (0.69–1.49) 1.02 (0.69–1.51) 0.84 (0.56–1.26) 0.46
Multivariate RR
b 1.0 1.03 (0.67–1.59) 1.03 (0.63–1.67) 1.09 (0.64–1.88) 0.93 (0.47–1.84) 0.98
Rectum cancer
c
Cases 58 49 45 51 50
Age-adjusted RR
a 1.0 0.83 (0.55–1.25) 0.78 (0.51–1.18) 0.90 (0.60–1.35) 0.87 (0.58–1.31) 0.67
Multivariate RR
b 1.0 0.81 (0.52–1.25) 0.76 (0.46–1.25) 0.89 (0.51–1.55) 0.91 (0.46–1.79) 0.90
aData presented as RR (95% confidence interval).
bThe model included age, family history of colorectal cancer, BMI, physical activity, energy-adjusted intakes of fat, fibre, calcium,
folate, beta-carotene, vitamin E, vitamin B6, alcohol, and energy intake.
cIncludes rectosigmoid.
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yTable 2 Relative rates (RRs) of colorectal cancer according to magnesium intake and BMI in men and women combined, Netherlands Cohort Study
1986–1999
Quintiles of energy-adjusted magnesium intake (mgday
 1)
Q1 Q2 Q3 Q4 Q5 P-trend
Quintile cutoffs (mgday
 1) o270 271–298 299–320 321–350 4350
Median (mgday
 1) 248 286 309 335 375
Person-years in subcohort 9707 9939 9956 9902 10077
Colorectal cancer
Cases 522 472 451 433 450
Multivariate RR
a 1.0 0.91 (0.76–1.09) 0.89 (0.73–1.08) 0.88 (0.70–1.10) 0.93 (0.70–1.23) 0.56
BMI o25kgm
 2
Cases 257 250 217 229 235
Multivariate RR
a 1.0 1.05 (0.82–1.35) 0.99 (0.75–1.31) 1.14 (0.83–1.57) 1.11 (0.75–1.64) 0.51
BMI X25kgm
 2
Cases 265 222 234 204 215
Multivariate RR
a 1.0 0.77 (0.59–1.01) 0.79 (0.59–1.05) 0.67 (0.48–0.93) 0.77 (0.50–1.18) 0.14
Colon cancer
Cases 365 327 298 290 298
Multivariate RR
a 1.0 0.89 (0.73–1.09) 0.83 (0.67–1.05) 0.85 (0.66–1.10) 0.91 (0.66–1.25) 0.48
BMI o25kgm
 2
Cases 172 170 141 153 160
Multivariate RR
a 1.0 1.09 (0.82–1.44) 0.99 (0.72–1.37) 1.20 (0.84–1.72) 1.22 (0.79–1.91) 0.34
BMI X25kgm
-2
Cases 193 157 157 137 138
Multivariate RR
a 1.0 0.72 (0.53–0.96) 0.69 (0.50–0.95) 0.60 (0.42–0.87) 0.67 (0.41–1.08) 0.05
Proximal colon cancer
Cases 169 167 145 134 149
Multivariate RR
a 1.0 0.91 (0.70–1.18) 0.80 (0.59–1.07) 0.75 (0.54–1.04) 0.82 (0.54–1.25) 0.18
BMI o25kgm
 2
Cases 78 87 64 71 80
Multivariate RR
a 1.0 1.19 (0.82–1.72) 0.96 (0.62–1.47) 1.13 (0.71–1.81) 1.25 (0.70–2.22) 0.64
BMI X25kgm
 2
Cases 91 80 81 63 69
Multivariate RR
a 1.0 0.69 (0.47–1.01) 0.65 (0.43–0.98) 0.48 (0.30–0.78) 0.54 (0.29–1.00) 0.02
Distal colon cancer
Cases 176 149 144 147 135
Multivariate RR
a 1.0 0.89 (0.68–1.17) 0.90 (0.67–1.22) 1.00 (0.72–1.39) 0.99 (0.64–1.53) 0.81
BMI o25kgm
 2
Cases 81 77 70 76 71
Multivariate RR
a 1.0 1.10 (0.75–1.60) 1.11 (0.72–1.71) 1.39 (0.87–2.24) 1.29 (0.71–2.36) 0.26
BMI X25kgm
 2
Cases 95 72 74 71 64
Multivariate RR
a 1.0 0.72 (0.49–1.07) 0.74 (0.48–1.13) 0.74 (0.46–1.18) 0.77 (0.40–1.49) 0.49
Rectum cancer
b
Cases 157 145 153 143 152
Multivariate RR
a 1.0 0.95 (0.72–1.25) 1.02 (0.75–1.38) 0.95 (0.67–1.35) 0.99 (0.64–1.52) 0.98
BMI o25kgm
 2
Cases 85 80 76 76 75
Multivariate RR
a 1.0 0.98 (0.67–1.43) 0.99 (0.65–1.52) 1.05 (0.64–1.72) 0.92 (0.50–1.71) 0.95
BMI X25kgm
 2
Cases 72 65 77 67 77
Multivariate RR
a 1.0 0.91 (0.60–1.39) 1.07 (0.69–1.67) 0.85 (0.50–1.44) 1.06 (0.54–2.05) 0.98
aThe model included age, sex, family history of colorectal cancer, BMI, physical activity, energy-adjusted intakes of fat, fibre, calcium, folate, beta-carotene, vitamin E, vitamin B6,
alcohol, and energy intake.
bIncludes rectosigmoid.
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ficant. Results for men and women separately were essentially
similar (data not shown).
DISCUSSION
An inverse association between magnesium intake and colorectal
cancer risk in women was first reported in a Swedish cohort study
(Larsson et al, 2005). In the Iowa Women’s Health Study, an
inverse association was found only for colon cancer. We found
weak inverse associations with risks of colorectal and colon cancer
in men and women, which were generally nonsignificant. In both
sexes, the inverse association was most evident for proximal colon
cancer risk. When we stratified by BMI level, the inverse
association was observed only in those with BMI X25kgm
 2.A s
overweight is related to decreased insulin sensitivity (Fung et al,
2003), this may suggest that magnesium is inversely associated
with colorectal cancer risk through improved insulin sensitivity.
Recently, magnesium intake was found to be associated with
increased levels of adiponectin, which may improve insulin
sensitivity (Qi et al, 2005); adiponectin was inversely associated
with colorectal cancer risk among men (Wei et al, 2005).
Strengths of our study include large numbers of cases, scope for
comparing the sexes, and the completeness of follow-up. We found
weaker inverse associations between colorectal cancer and
magnesium intake than in the Sweden (Larsson et al, 2005) and,
to a lesser extent, Iowa studies (Folsom and Hong, 2006). It may be
relevant that reported magnesium intake levels are lower in
Sweden than in the Netherlands: median intakes in lowest and
highest quintiles were 198 and 268mgday
 1 (Larsson et al, 2005),
and 236 and 349mgday
 1 in Dutch women, respectively.
Magnesium intake of up to 325mgday
 1 was recently found to
be associated with insulin sensitivity, and intakes above this level
might not provide further benefits; sex-specific data were not
presented (Ma et al, 2006). We observed no further decrease in
risk in our subsite-specific analyses (Table 2) in quintile 5
(4350mgday
 1; median 375) compared to quintile 4 (321–
350mgday
 1; median 313), which is in line with the threshold
finding. The magnesium intake in Iowa women (Folsom and Hong,
2006) was comparable to our study, but Iowa women were
generally heavier (Folsom and Hong, 2006) than Dutch women,
which could explain the different findings given the modification
by BMI.
In conclusion, our results provide no clear support for an overall
protective effect of magnesium on colorectal cancer in men or
women, but are compatible with an impact in the subgroup of
overweight subjects, possibly through reduced insulin resistance.
Further studies are needed to elucidate this relationship.
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